CN102669681A - Nutrition health care product for protecting gastrointestinal mucosa - Google Patents
Nutrition health care product for protecting gastrointestinal mucosa Download PDFInfo
- Publication number
- CN102669681A CN102669681A CN201210190022XA CN201210190022A CN102669681A CN 102669681 A CN102669681 A CN 102669681A CN 201210190022X A CN201210190022X A CN 201210190022XA CN 201210190022 A CN201210190022 A CN 201210190022A CN 102669681 A CN102669681 A CN 102669681A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- gastrointestinal
- health care
- gastrointestinal mucosa
- care product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to the technical field of health care medicine food, in particular to a nutrition health care product for protecting gastrointestinal mucosa. The nutrition health care product for protecting the gastrointestinal mucosa comprises gamma-oryzanol, ribonucleic acid (RNA) yeasts, vitamin B1, vitamin B2, vitamin B6, vitamin B12, niacinamide, calcium polyoxovanadate or polycarboxylic acid and vitamin C according to a certain proportioning quantity. After the nutrition health care product provided by the invention is taken, the gastrointestinal mucosa is effectively protected, the support and protection effect is realized on the gastrointestinal mucosa seepage phenomenon, the gastrointestinal function is effectively regulated, the nutrition absorption is increased, the gastrointestinal senium is delayed, enterotoxin is eliminated, the gastrointestinal immunity is improved, the occurrence of gastrointestinal cancer is prevented, and in addition, the nutrition health care product has the characteristics that nontoxicity, harmlessness and no side effects are realized, the therapeutic effect is permanent, and the quality is mild.
Description
Technical field
The present invention relates to the health medicine food technology field, refer in particular to a kind of nutrient and healthcare products of protecting gastrointestinal mucosa.
Background technology
In the society, along with the enhancing of rhythm of life and the irregular state of diet, increasing people has intestines and stomach disease in various degree in modern times; The intestines and stomach disease is embodied in, but enteritis, gastritis, diarrhoea or the like, and the most applications gastrointestinal mucosa receives damage in various degree; Make the intestines and stomach enteron aisle in disorder, the nutrient absorption miopragia, stomach and intestine are old and feeble; The accumulation of intestines and stomach toxin, immune system go wrong, if mustn't go to treatment timely to handle, can increase the incidence of human primary gastrointestinal cancers.
The methods of treatment that most of people adopt, multiselect be with the treatment of Western medicine, yet for the impaired GI disease of gastrointestinal mucosa; Western medicine is generally understood the stimulating gastrointestinal road; Make originally impaired gastrointestinal mucosa further impaired, side effect is quite big, the long-time balance that is easy to destroy body of using; Aggravate disease, also might cause growing of other diseases.
Summary of the invention
The present invention is directed to the gastrointestinal tract mucous impaired deficiency of accepting the drug therapy existence of present enterogastric diseases, and a kind of nutrient and healthcare products of protecting gastrointestinal mucosa are provided, for realizing above purpose, the present invention adopts following technical scheme:
A kind of nutrient and healthcare products of protecting gastrointestinal mucosa, it is following that the every dosage of said health products contains effective health therapy composition: gamma oryzanol 45-65mg, RNA yeast 15-32mg, vitamin B1 28-42mg, vitamin B2 8-22mg, vitamin B6 4-12mg, cobalamin 5-12 μ g, Nicotinic Acid Amide 25-35mg, calcium pantothenate or this polyacid 15-28mg, vitamin C 220-350mg.
Preferable, the deal of said each composition is: gamma oryzanol 50mg, RNA yeast 20mg, vitamin B1 30mg, vitamin B2 15mg, vitamin B6 5mg, cobalamin 10 μ g, Nicotinic Acid Amide 30mg, calcium pantothenate (or this polyacid) 20mg, vitamin C 300mg.
Preferable, said health products are capsule or oral liquid.
Beneficial effect of the present invention is: the nutrient and healthcare products of protection gastrointestinal mucosa of the present invention, and comprise gamma oryzanol, RNA yeast, vitamin B1, vitamin B2, vitamin B6, cobalamin, Nicotinic Acid Amide, calcium pantothenate or this polyacid, the vitamin C of certain proportional quantity and form, take back nutrient and healthcare products of the present invention; Effectively protect gastrointestinal mucosa; Gastrointestinal mucosa seepage phenomenon is had the supportive protection effect, effectively adjust gastrointestinal function, absorption has additional nutrients; Delaying stomach and intestine is old and feeble; Remove enterotoxin, improve intestines and stomach immunity, the generation of prevention gastric and intestinal cancer; And have nontoxic, harmless, have no side effect, curative effect is lasting, the characteristics that quality is gentle.
The specific embodiment:
Below in conjunction with specific embodiment the present invention is further specified:
Embodiment 1:
A kind of nutrient and healthcare products of protecting gastrointestinal mucosa, it is following that the every dosage of said health products contains effective health therapy composition: gamma oryzanol 45mg, RNA yeast 32mg, vitamin B1 28mg, vitamin B2 22mg, vitamin B6 4mg, cobalamin 12 μ g, Nicotinic Acid Amide 25mg, this polyacid (also can adopt calcium pantothenate) 28mg, vitamin C 220mg.
About the form of health products of the present invention, the present invention does not do concrete restriction, and those skilled in the art add the suitable additive that allows according to basic general knowledge and demand in prescription, can produce capsule, oral liquid or the like.
Embodiment 2:
Enumerate the nutrient and healthcare products of the protection gastrointestinal mucosa of another kind of prescription in the present embodiment, it is following that the every dosage of health products contains effective health therapy composition: it is following that the every dosage of said health products contains effective health therapy composition: gamma oryzanol 65mg, RNA yeast 15mg, vitamin B1 42mg, vitamin B2 8mg, vitamin B6 12mg, cobalamin 5 μ g, Nicotinic Acid Amide 35mg, calcium pantothenate (also can adopt this polyacid) 15mg, vitamin C 350mg.
Embodiment 3:
As a preferred embodiment; Each composition of nutrient and healthcare products of kind protection gastrointestinal mucosa of the present invention is preferable with following proportioning effect, gamma oryzanol 50mg, RNA yeast 20mg, vitamin B1 30mg, vitamin B2 15mg, vitamin B6 5mg, cobalamin 10 μ g, Nicotinic Acid Amide 30mg, calcium pantothenate (also can adopt this polyacid) 20mg, vitamin C 300mg.
The nutrient and healthcare products of kind protection gastrointestinal mucosa of the present invention are all obtained good curative effect in various degree through a lot of clinical verifications.Enumerate a case wherein at present: so-and-so man of beam 45 years old, frequent diarrhoea stomachache, health is day by day become thin, and diet is careless slightly; The abdominal distension of both having suffered from diarrhoea, endoscopy is diagnosed as chronic ulcerative colitis, and gastrointestinal mucosa is impaired serious; Gastric mucosa nutrient and healthcare products of the present invention are taken in suggestion, sooner or later respectively take a dosage, take continuously 3 months; Diarrhoea stomachache disappears, and it is normal that the endoscopy gastrointestinal mucosa recovers, and does not have other not recurrences of uncomfortable reaction.
The above embodiment; It is preferred embodiments of the present invention; Be not to limit practical range of the present invention,, all should be included in the patent claim of the present invention so all equivalences of doing according to the described structure of claim of the present invention, characteristic and principle change or modify.
Claims (3)
1. nutrient and healthcare products of protecting gastrointestinal mucosa; It is characterized in that it is following that the every dosage of said health products contains effective health therapy composition: gamma oryzanol 45-65mg, RNA yeast 15-32mg, vitamin B1 28-42mg, vitamin B2 8-22mg, vitamin B6 4-12mg, cobalamin 5-12 μ g, Nicotinic Acid Amide 25-35mg, calcium pantothenate or this polyacid 15-28mg, vitamin C 220-350mg.
2. a kind of nutrient and healthcare products of protecting gastrointestinal mucosa according to claim 1; It is characterized in that the deal of said each composition is: gamma oryzanol 50mg, RNA yeast 20mg, vitamin B1 30mg, vitamin B2 15mg, vitamin B6 5mg, cobalamin 10 μ g, Nicotinic Acid Amide 30mg, calcium pantothenate (or this polyacid) 20mg, vitamin C 300mg.
3. a kind of nutrient and healthcare products of protecting gastrointestinal mucosa according to claim 1 and 2 is characterized in that said health products are capsule or oral liquid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210190022XA CN102669681A (en) | 2012-06-09 | 2012-06-09 | Nutrition health care product for protecting gastrointestinal mucosa |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210190022XA CN102669681A (en) | 2012-06-09 | 2012-06-09 | Nutrition health care product for protecting gastrointestinal mucosa |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102669681A true CN102669681A (en) | 2012-09-19 |
Family
ID=46802768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210190022XA Pending CN102669681A (en) | 2012-06-09 | 2012-06-09 | Nutrition health care product for protecting gastrointestinal mucosa |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102669681A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1171898A (en) * | 1997-04-13 | 1998-02-04 | 陈冠卿 | Kangwei food for preventing and curing gastrosia and its preparing method |
CN1647819A (en) * | 2004-01-19 | 2005-08-03 | 耿东进 | Use of active enzyme and composition in preventing and treating gastropathy and cosmetics fields |
CN101801391A (en) * | 2007-07-23 | 2010-08-11 | 农业工业研究发展公司 | Use of hyaluronic acid for preparing compositions particularly for improving the function of skin, eye and mucous membrane protection |
-
2012
- 2012-06-09 CN CN201210190022XA patent/CN102669681A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1171898A (en) * | 1997-04-13 | 1998-02-04 | 陈冠卿 | Kangwei food for preventing and curing gastrosia and its preparing method |
CN1647819A (en) * | 2004-01-19 | 2005-08-03 | 耿东进 | Use of active enzyme and composition in preventing and treating gastropathy and cosmetics fields |
CN101801391A (en) * | 2007-07-23 | 2010-08-11 | 农业工业研究发展公司 | Use of hyaluronic acid for preparing compositions particularly for improving the function of skin, eye and mucous membrane protection |
Non-Patent Citations (1)
Title |
---|
王本坚,等: "谷维素的临床新用途", 《中国临床医生》, vol. 23, no. 1, 31 December 2004 (2004-12-31) * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2886951T3 (en) | Composition for use in modulating the microbiota | |
US11998558B2 (en) | Synthetic composition for treating antibiotic associated complications | |
Martinez-Estevez et al. | Effects of zinc supplementation in the prevention of respiratory tract infections and diarrheal disease in Colombian children: A 12-month randomised controlled trial | |
WO2017148596A1 (en) | Compositions comprising bacterial blautia strains for treating visceral hypersensitivity | |
JP2013146281A (en) | Dietary supplement | |
ES2365469T3 (en) | TREATMENT OF GENERALIZED DISORDERS OF DEVELOPMENT. | |
EA200802038A1 (en) | PHARMACEUTICAL COMPOSITION OF ENTEROSORBENT AND PREBIOTICS, MEDICAL FORMS AND METHOD OF PREVENTION AND TREATMENT OF DISEASES OF THE GASTROINTESTINAL TRACT | |
WO2015010449A1 (en) | Method for use of vitamin b composition to promote motility of gastrointestinal system | |
JP2014524478A5 (en) | ||
US20120065266A1 (en) | Oral composition | |
CN102669681A (en) | Nutrition health care product for protecting gastrointestinal mucosa | |
CN102783640B (en) | Nutrition health care product for promoting digestive tract immunity | |
CN103082299B (en) | Nutritional healthcare product for clearing bowels and expelling toxin | |
Hanevik et al. | Tolerability and effect of mesalazine in postinfectious irritable bowel syndrome | |
CN101444575B (en) | Chinese herbal medicine for treating esophagus disease | |
US20240180986A1 (en) | Compositions and methods for treating and preventing gastrointestinal inflammation | |
Levy et al. | Hiccups as a presenting symptom of eosinophilic esophagitis | |
CN102512652B (en) | Medicinal composition for treating peptic ulcer | |
WO2011100668A4 (en) | Methods and compositions of civamide to treat diseases of the intestines | |
CN101890158A (en) | Prescription and preparation method of mixture for tonifying stomach and promoting digestion | |
CN103845693A (en) | Changweikang | |
BR102017021491A2 (en) | NUTRITIONAL SUPPLEMENT KIT FOR BARIATRIC SURGERY PATIENTS | |
JP6841223B2 (en) | Exercise-induced gastrointestinal disorder improver | |
CN114569618A (en) | Compound preparation of cefaclor and preparation method thereof | |
Patil et al. | AN OVERVIEW OF TREATMENT MODALITIES FOR PEPTIC ULCER |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120919 |